Godbout Sean
SEC CIK 2057736 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BIIB | Biogen | CAO | 1,396 | — | — | 6 | 2025-10-02 | 2026-04-01 |
Most active insiders at BIIB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Singhal Priya | Head of Development | — | $665.7K |
| 2 | Minor Lloyd | Dir | — | $239.7K |
| 3 | Murphy Nicole | Head of Pharm Ops, Tech | $585.12 | — |
| 4 | Godbout Sean | CAO | — | — |
| 5 | Pangalos Menelas N | Dir | — | — |
| 6 | Grogan Jane | Head of Research | — | — |
| 7 | LANGER SUSAN | Dir | — | — |
| 8 | Keeney Adam | Head of Corp. Development | — | — |
| 9 | Izzar Rachid | Head of Gbl Product Strat | — | — |
| 10 | Patolawala Monish D | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-03 16:05 | 2026-04-01 | BIIB | Biogen | Godbout Sean | CAO | M - OptEx | $0.00 | +181 | 1,396 | +15% | $0 |
| D | 2026-04-03 16:05 | 2026-04-01 | BIIB | Biogen | Godbout Sean | CAO | F - Tax | $183.78 | -54 | 1,342 | -4% | -$9,924 |
| DM | 2026-02-10 | 2026-02-06 | BIIB | Biogen | Godbout Sean | CAO | M - OptEx | $0.00 | +1,079 | 980.67 | New | $0 |
| DM | 2026-02-10 | 2026-02-06 | BIIB | Biogen | Godbout Sean | CAO | F - Tax | $201.18 | -359 | 1,215 | -23% | -$72.2K |
| D | 2025-10-06 | 2025-10-02 | BIIB | Biogen | Godbout Sean | CAO | M - OptEx | $0.00 | +26 | 502.67 | +5% | $0 |
| D | 2025-10-06 | 2025-10-02 | BIIB | Biogen | Godbout Sean | CAO | F - Tax | $155.25 | -8 | 494.67 | -2% | -$1,242 |
Purchase Sale Sale after option exercise All abbreviations